Cystic fibrosis–related diabetes is caused by islet loss and inflammation

Nathaniel Hart(Vanderbilt University Medical Center), Radhika Aramandla(Vanderbilt University Medical Center), Gregory Poffenberger(Vanderbilt University Medical Center), Cody Fayolle(Vanderbilt University Medical Center), Ariel Helms Thames(Vanderbilt University Medical Center), Austin Bautista(University of Alberta), Aliya F Spigelman(University of Alberta), Jenny Aurielle B. Babon(University of Massachusetts Chan Medical School), Megan DeNicola(University of Massachusetts Chan Medical School), Prasanna K. Dadi(Vanderbilt University), William S. Bush(Case Western Reserve University), Appakalai N. Balamurugan(Cardiovascular Innovation Institute), Marcela Briššová(Vanderbilt University Medical Center), Chunhua Dai(Vanderbilt University Medical Center), Nripesh Prasad(HudsonAlpha Institute for Biotechnology), Rita Bottino(Allegheny-Singer Research Institute), David A. Jacobson(Vanderbilt University), Mitchell L. Drumm(Case Western Reserve University), Sally C. Kent(University of Massachusetts Chan Medical School), Patrick E. MacDonald(University of Alberta), Alvin C. Powers(Vanderbilt University)
JCI Insight
April 18, 2018
Cited by 183Open Access
Full Text

Abstract

Cystic fibrosis-related (CF-related) diabetes (CFRD) is an increasingly common and devastating comorbidity of CF, affecting approximately 35% of adults with CF. However, the underlying causes of CFRD are unclear. Here, we examined cystic fibrosis transmembrane conductance regulator (CFTR) islet expression and whether the CFTR participates in islet endocrine cell function using murine models of β cell CFTR deletion and normal and CF human pancreas and islets. Specific deletion of CFTR from murine β cells did not affect β cell function. In human islets, CFTR mRNA was minimally expressed, and CFTR protein and electrical activity were not detected. Isolated CF/CFRD islets demonstrated appropriate insulin and glucagon secretion, with few changes in key islet-regulatory transcripts. Furthermore, approximately 65% of β cell area was lost in CF donors, compounded by pancreatic remodeling and immune infiltration of the islet. These results indicate that CFRD is caused by β cell loss and intraislet inflammation in the setting of a complex pleiotropic disease and not by intrinsic islet dysfunction from CFTR mutation.


Related Papers

No related papers found

Powered by citation graph analysis